Comparative cytochemical study of dipeptidyl aminopeptidase (DAP) II and IV in normal and malignant haemic cells.

Modified cytochemical methods were used to show dipeptidyl aminopeptidases (DAP) II and IV in peripheral blood buffy coat preparations and bone marrow smears. In 23 normal buffy coats both enzymes were confined to lymphocytes. DAP II was found in T and B lymphocytes (about 80%) while DAP IV was restricted to T lymphocytes only (around 46%). In 11 normal bone marrows DAP II was found in 53% of the lymphocytes, as well as in plasma cells, macrophages, and occasional myeloblasts. DAP IV was found only in lymphocytes (around 32%). DAP II activity, but not DAP IV activity, was present in all of the mast cells in a case of systemic mastocytosis. Whereas DAP II was found, to a variable extent, in leukaemic myeloblasts, monoblasts, proerythroblasts, and in megakaryoblasts in 52 cases of acute myeloid leukaemia, DAP IV was not shown. Variable positivity to DAP II and DAP IV was found in the lymphoblasts in seven cases of acute lymphoblastic leukaemia, in 14 cases of B chronic lymphocytic leukaemia, and in three cases of non-Hodgkin's lymphoma. DAP II activity was variable compared with DAP IV activity, which was constantly reduced. Virtually all of the myeloma cells (96%) all of the myeloma cells (96%) in five cases of multiple myeloma and two cases of plasma cell leukaemia were DAP II positive and DAP IV negative. In 10 cases of hairy cell leukaemia most hairy cells were positive to DAP II (74%) with no demonstrable DAP IV activity. In a single case of Sézary's syndrome around 90% of the helper T cells were positive to DAP II with no DAP IV activity.

[1]  D. Dennig,et al.  Dipeptidylaminopeptidase IV (DAP IV) activity in normal and malignant T-cell subsets as defined by monoclonal antibodies. , 2009, Scandinavian journal of haematology.

[2]  F. Hayhoe,et al.  Histochemistry of dipeptidyl aminopeptidase (DAP) II and IV in reactive lymphoid tissues and malignant lymphoma. , 1987, Journal of clinical pathology.

[3]  D. Catovsky,et al.  Dipeptidylaminopeptidase IV activity in normal and leukemic T-cell subpopulations. , 1984, American journal of clinical pathology.

[4]  I. Goldschneider Heterogeneity of bone marrow 'lymphocytes'. , 1982, Clinics in haematology.

[5]  F. Menestrina,et al.  Dipeptidyl(amino)peptidase IV (DAP-IV) histochemistry on normal and pathologic lymphoid tissues. , 1982, American journal of clinical pathology.

[6]  A. Feller,et al.  Enzymehistochemical staining of Tμ lymphocytes for glycyl‐proline‐4‐methoxy‐beta‐naphthylamide‐peptidase (DAP IV) , 1982, British journal of haematology.

[7]  Z. Lojda Proteinases in pathology. Usefulness of histochemical methods , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[8]  E. Benešová,et al.  [Dipeptidylaminopeptidase IV in lymphocytes of peripheral blood of man and the importance of its evidence in malignant lymphomas (author's transl)]. , 1979, Sbornik lekarsky.

[9]  Z. Lojda,et al.  Enzyme Histochemistry: A Laboratory Manual , 1979 .

[10]  M. E. Kaplan,et al.  An improved rosetting assay for detection of human T lymphocytes. , 1974, Journal of immunological methods.

[11]  K. Lennert,et al.  Cytochemical distribution of dipeptidylaminopeptidase IV (DAP IV; EC-3.4.14.5) in T-lymphoblastic lymphoma/leukemia characterized with monoclonal antibodies. , 1984, Leukemia research.

[12]  A. Meijer [Enzyme histochemistry]. , 1975, Acta histochemica. Supplementband.